Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00002139 · ClinicalTrials.gov registry record · Phase 1

Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects.

A Phase 1 study of HIV Infections and Bacterial Infections, sponsored by Pfizer.

Completed
Registry status
Phase 1
Development phase
1
Study location

NCT00002139 is a Phase 1 study of HIV Infections and Bacterial Infections that has completed, run by Pfizer. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00002139, a Phase 1 study of HIV Infections and Bacterial Infections, has completed, sponsored by Pfizer.

COMPLETED
Registry status
Phase 1
Development phase
1
Study location

Study Summary

To compare the uptake of azithromycin in white cells relative to plasma concentrations in HIV-infected patients.

Conditions Studied

HIV Infections Bacterial Infections

Interventions

  • DRUG Azithromycin

Study Locations (1)

Kansas

  • Ctr for Phase I Research - Wichita

Trial Details

FieldValue
Phase Phase 1

Sponsor

Pfizer

1,845 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00002139

The ClinicalTrials.gov registry entry for NCT00002139 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Azithromycin is the first listed.

NCT00002139 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.

Frequently Asked Questions

What is clinical trial NCT00002139 about?

NCT00002139 is a clinical study titled "Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects.". To compare the uptake of azithromycin in white cells relative to plasma concentrations in HIV-infected patients.

What is the current status of trial NCT00002139?

This trial is currently completed. It is a Phase 1 study.

What conditions does trial NCT00002139 study?

This clinical trial studies the following conditions: HIV Infections, Bacterial Infections.

What interventions are being tested in trial NCT00002139?

The interventions under investigation include: Azithromycin (DRUG).

Who is sponsoring clinical trial NCT00002139?

This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00002139 being conducted?

This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

Bacterial Infections

All registered trials for this condition

Kansas

All trials with a study site in Kansas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.